carvedilol has been researched along with sb 203580 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dun, Y; Sun, HY; Zhao, RR; Zhao, ZQ; Zhi, JM | 1 |
Altieri, P; Ballestrero, A; Barisione, C; Barsotti, A; Brunelli, C; Fabbi, P; Garibaldi, S; Ghigliotti, G; Manca, V; Spallarossa, P | 1 |
2 other study(ies) available for carvedilol and sb 203580
Article | Year |
---|---|
Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol.
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Carbazoles; Carvedilol; Cells, Cultured; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; Imidazoles; In Situ Nick-End Labeling; Microscopy, Electron; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Neutrophils; p38 Mitogen-Activated Protein Kinases; Platelet Activating Factor; Propanolamines; Pyridines; Rats; Signal Transduction | 2002 |
Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase.
Topics: Anthracenes; Antibiotics, Antineoplastic; Antioxidants; Blotting, Western; Carbazoles; Carvedilol; Catecholamines; Cell Line; Doxorubicin; Enzyme Activation; Flavonoids; Humans; Imidazoles; Imidazolines; Janus Kinase 1; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Propanolamines; Protein-Tyrosine Kinases; Pyridines; Razoxane | 2006 |